SYNEKTIK SPÓLKA AKCYJNA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.8 PLN | -3.68% |
|
+1.62% | +46.28% |
| Sales 2024 * | 518M 129M | Sales 2025 * | 521M 129M | Capitalization | 1.07B 267M |
|---|---|---|---|---|---|
| Net income 2024 * | 73M 18.15M | Net income 2025 * | 64M 15.91M | EV / Sales 2024 * | 1.92 x |
| Net cash position 2024 * | 78.68M 19.56M | Net cash position 2025 * | 88.79M 22.08M | EV / Sales 2025 * | 1.89 x |
| P/E ratio 2024 * |
14.7
x | P/E ratio 2025 * |
13.9
x | Employees | 165 |
| Yield 2024 * |
2.73% | Yield 2025 * |
2.24% | Free-Float | 49.86% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.68% | ||
| 1 week | +1.62% | ||
| Current month | -15.85% | ||
| 1 month | -13.54% | ||
| 3 months | +49.41% | ||
| 6 months | +104.89% | ||
| Current year | +46.28% |
1 week
122.60
132.80
1 month
117.00153.50
Current year
80.80157.00
1 year
51.00157.00
3 years
22.50157.00
5 years
10.20157.00
10 years
8.56157.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01-10-03 | |
| Founder | - | 01-10-03 | |
| Director/Board Member | - | 11-01-10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 52 | 18-04-09 | |
| Director/Board Member | 58 | 17-10-15 | |
Dariusz Daniluk
BRD | Director/Board Member | 60 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 125.8 | -3.68% | 23,544 |
| 24-04-24 | 130.6 | +0.93% | 12,856 |
| 24-04-23 | 129.4 | +0.31% | 23,955 |
| 24-04-22 | 129 | +5.22% | 33,762 |
| 24-04-19 | 122.6 | -0.97% | 35,989 |
Delayed Quote Warsaw S.E., April 25, 2024 at 11:55 am EDT
More quotes
Synektik SA is a Poland-based company active in the medical sector. It produces PACS software which allows running a diagnostic imaging laboratory. It runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The Company sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.
Calendar
2024-06-10
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
125.8
PLN
Average target price
119
PLN
Spread / Average Target
-5.37%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +46.28% | 266M | |
| +7.71% | 218B | |
| +6.25% | 182B | |
| +10.60% | 132B | |
| +26.73% | 108B | |
| -0.57% | 62.51B | |
| +15.42% | 52.98B | |
| -1.89% | 47.59B | |
| -1.91% | 39.96B | |
| +11.16% | 39.22B |
- Stock Market
- Equities
- SNT Stock
